Why the study?
Many patients with hypertension fail to achieve target BP control, and resistant hypertension carries a high risk of organ damage and cardiovascular disease, necessitating early identification and effective management.
Early identification and effective management of resistant hypertension are crucial to lower cardiovascular morbidity and mortality.
Underscores need for prompt resistant hypertension intervention to reduce events; leaves open comparative effectiveness of emerging therapies.
Hypertension is one of the leading causes of death globally Despite the widespread use of antihypertensive drugs and treatment strategies, many patients with hypertension fail to achieve target blood pressure (BP) control, a condition called resistant hypertension (RH). RH is a major clinical problem as it is associated with a high risk of hypertension-mediated organ damage (HMOD), including chronic kidney disease (CKD), and premature cardiovascular diseases (CVD) Therefore, early identification and effective management strategies have the potential to improve hypertension treatment and lower cardiovascular morbidity and mortality of the hypertensives population, especially RH.
No takes yet. Share an insight, caveat, or question.
Alsharari et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: